SO
RLAY icon

STRS Ohio’s Relay Therapeutics RLAY Stock Holding History

STRS Ohio’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Buy
+18,700
New +$271K ﹤0.01% 1330
2022
Q2 		– Sell
-800
Closed -$23K – 2245
2022
Q1 		$23K Sell
800
-2,300
-74% -$55.8K ﹤0.01% 2031
2021
Q4 		$95K Hold
3,100
– – ﹤0.01% 1905
2021
Q3 		$97K Buy
+3,100
New +$104K ﹤0.01% 1948
2020
Q4 		– Sell
-8,000
Closed -$340K – 2259
2020
Q3 		$340K Buy
+8,000
New +$305K ﹤0.01% 1519

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

STRS Ohio's RLAY Position: Q2 2026 in Review

STRS Ohio opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 18,700 shares worth $350K. The stake represents ﹤0.01% of the portfolio and ranks #1330 among its holdings. This is a return to the name: STRS Ohio previously reported a position in RLAY as recently as Q1 2022.

STRS Ohio first reported a position in RLAY in Q3 2020 and has held it in 5 quarters since. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • STRS Ohio held 18,700 shares of Relay Therapeutics worth $350K as of Q2 2026.
  • Relay Therapeutics was a new STRS Ohio position in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1330 holding.
  • STRS Ohio first reported a position in Relay Therapeutics in Q3 2020 and has held it in 5 quarters since.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.